Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody–drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates
Crossref DOI link: https://doi.org/10.1007/s00280-014-2500-2
Published Online: 2014-06-18
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Dan
Girish, Sandhya
Gao, Yuying
Wang, Bei
Yi, Joo-Hee
Guardino, Ellie
Samant, Meghna
Cobleigh, Melody
Rimawi, Mothaffar
Conte, Pierfranco
Jin, Jin Yan
License valid from 2014-06-18